Literature DB >> 24657887

Role of osteopontin in the pathophysiology of cancer.

Lalita A Shevde1, Rajeev S Samant2.   

Abstract

Osteopontin (OPN) is a multifunctional cytokine that impacts cell proliferation, survival, drug resistance, invasion, and stem like behavior. Due to its critical involvement in regulating cellular functions, its aberrant expression and/or splicing is functionally responsible for undesirable alterations in disease pathologies, specifically cancer. It is implicated in promoting invasive and metastatic progression of many carcinomas. Due to its autocrine and paracrine activities OPN has been shown to be a crucial mediator of cellular cross talk and an influential factor in the tumor microenvironment. OPN has been implicated as a prognostic and diagnostic marker for several cancer types. It has also been explored as a possible target for treatment. In this article we hope to provide a broad perspective on the importance of OPN in the pathophysiology of cancer. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer; Isoforms; Matricellular; Osteopontin; Signaling

Mesh:

Substances:

Year:  2014        PMID: 24657887      PMCID: PMC5916777          DOI: 10.1016/j.matbio.2014.03.001

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  165 in total

1.  Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.

Authors:  V Samanna; H Wei; D Ego-Osuala; M A Chellaiah
Journal:  Exp Cell Res       Date:  2006-04-24       Impact factor: 3.905

2.  The O‑glycosylation mutant osteopontin alters lung cancer cell growth and migration in vitro and in vivo.

Authors:  Arash Minai-Tehrani; Seung-Hee Chang; Seung Bum Park; Myung-Haing Cho
Journal:  Int J Mol Med       Date:  2013-09-05       Impact factor: 4.101

3.  Osteopontin induces multiple changes in gene expression that reflect the six "hallmarks of cancer" in a model of breast cancer progression.

Authors:  Amy C Cook; Alan B Tuck; Susan McCarthy; Joel G Turner; Rosalyn B Irby; Gregory C Bloom; Timothy J Yeatman; Ann F Chambers
Journal:  Mol Carcinog       Date:  2005-08       Impact factor: 4.784

4.  Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.

Authors:  Gisle Berge; Solveig Pettersen; Ida Grotterød; Ingrid J Bettum; Kjetil Boye; Gunhild M Mælandsmo
Journal:  Int J Cancer       Date:  2011-03-11       Impact factor: 7.396

5.  Nonclassical activation of Hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to Smoothened-targeting Hedgehog inhibition.

Authors:  Shamik Das; Rajeev S Samant; Lalita A Shevde
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

6.  Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo.

Authors:  Sang Hyuk Hong; Hyo-Jung Lee; Eun Jung Sohn; Hyun-Suk Ko; Bum Sang Shim; Kyoo Seok Ahn; Sung-Hoon Kim
Journal:  Pharmacol Rep       Date:  2013       Impact factor: 3.024

7.  Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis.

Authors:  A Laffón; R García-Vicuña; A Humbría; A A Postigo; A L Corbí; M O de Landázuri; F Sánchez-Madrid
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

8.  Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma.

Authors:  Aikaterini Sfiridaki; Spiros Miyakis; Constantina Pappa; George Tsirakis; Athanasios Alegakis; Vasileios Kotsis; Efstathios Stathopoulos; Michael Alexandrakis
Journal:  J Hematol Oncol       Date:  2011-05-08       Impact factor: 17.388

9.  The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis.

Authors:  Christel van den Hoogen; Geertje van der Horst; Henry Cheung; Jeroen T Buijs; Rob C M Pelger; Gabri van der Pluijm
Journal:  Clin Exp Metastasis       Date:  2011-06-07       Impact factor: 5.150

10.  Plasma osteopontin is a useful diagnostic biomarker for advanced non-small cell lung cancer.

Authors:  Seon-Sook Han; Seung-Joon Lee; Woo Jin Kim; Dong Ryeol Ryu; Jun Yeon Won; Shinyoung Park; Myeong Ju Cheon
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-09-30
View more
  89 in total

Review 1.  Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  Adv Drug Deliv Rev       Date:  2016-01-04       Impact factor: 15.470

2.  Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.

Authors:  David D Roberts; Sukhbir Kaur; Jeffrey S Isenberg
Journal:  Antioxid Redox Signal       Date:  2017-09-08       Impact factor: 8.401

3.  Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesis.

Authors:  Karl Katholnig; Birgit Schütz; Stephanie D Fritsch; David Schörghofer; Monika Linke; Nyamdelger Sukhbaatar; Julia M Matschinger; Daniela Unterleuthner; Martin Hirtl; Michaela Lang; Merima Herac; Andreas Spittler; Andreas Bergthaler; Gernot Schabbauer; Michael Bergmann; Helmut Dolznig; Markus Hengstschläger; Mark A Magnuson; Mario Mikula; Thomas Weichhart
Journal:  JCI Insight       Date:  2019-10-17

4.  Correlation between calcification and bone sialoprotein and osteopontin in papillary thyroid carcinoma.

Authors:  Gang Wu; Jing-Jing Guo; Zhen-Yu Ma; Jie Wang; Zhong-Wen Zhou; Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

5.  Osteopontin and the immune system: another brick in the wall.

Authors:  Sara Caputo; Matteo Bellone
Journal:  Cell Mol Immunol       Date:  2017-10-02       Impact factor: 11.530

6.  Cancer Secretome May Influence BSP and DSP Expression in Human Salivary Gland Cells.

Authors:  Samantha Lynn Hamilton; Blake Ferando; Asha Sarah Eapen; Jennifer Chian Yu; Anita Rose Joy
Journal:  J Histochem Cytochem       Date:  2016-11-25       Impact factor: 2.479

7.  DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer.

Authors:  Daniela Kurfurstova; Jirina Bartkova; Radek Vrtel; Alena Mickova; Alena Burdova; Dusana Majera; Martin Mistrik; Milan Kral; Frederic R Santer; Jan Bouchal; Jiri Bartek
Journal:  Mol Oncol       Date:  2016-03-03       Impact factor: 6.603

8.  Obesity-Associated Extracellular Matrix Remodeling Promotes a Macrophage Phenotype Similar to Tumor-Associated Macrophages.

Authors:  Nora L Springer; Neil M Iyengar; Rohan Bareja; Akanksha Verma; Maxine S Jochelson; Dilip D Giri; Xi K Zhou; Olivier Elemento; Andrew J Dannenberg; Claudia Fischbach
Journal:  Am J Pathol       Date:  2019-07-16       Impact factor: 4.307

Review 9.  Skeletal biology: Where matrix meets mineral.

Authors:  Marian F Young
Journal:  Matrix Biol       Date:  2016-04-27       Impact factor: 11.583

10.  Genetic lineage tracing analysis of the cell of origin of hepatotoxin-induced liver tumors in mice.

Authors:  Soona Shin; Kirk J Wangensteen; Monica Teta-Bissett; Yue J Wang; Elham Mosleh-Shirazi; Elizabeth L Buza; Linda E Greenbaum; Klaus H Kaestner
Journal:  Hepatology       Date:  2016-05-28       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.